Navigation Links
Frost & Sullivan Recognizes Life Technologies for Excellence in the Life Science Research Tools Industry
Date:3/24/2009

MOUNTAIN VIEW, Calif., March 24 /PRNewswire/ -- Based on its recent analysis of the drug discovery technologies market, Frost & Sullivan recognizes Life Technologies with the 2009 North American Frost & Sullivan Company of the Year Award. The company's size, product portfolio breadth, market segment leadership, and strong future potential set it apart from any competitor in the life science research tools industry. Moreover, Life Technologies shows great commitment to providing innovative and enabling tools across the life science research continuum.

(Logo: http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO)

Formed from the combination of Invitrogen and Applied Biosystems, Life Technologies is on a clear path to become its own unique organization with unparalleled efficiency and speed of operation. More importantly, the reengineered Life Technologies promises extraordinary revenue growth that far outpaces the performance of its two predecessor companies.

"Prior to the 2008 merger, Applied Biosystems held the largest percentage of market share in the microRNA, PCR reagents, capillary electrophoresis sequencing, qRT-PCR, and life sciences mass spectrometry markets, while Invitrogen held the largest percentage of market share in the cell culture and protein expression and purification markets," explains Jonathan Witonsky, Industry Manager, Drug Discovery & Clinical Diagnostics, Frost & Sullivan. "By merging, the new company, Life Technologies, holds a significant market share in nine additional market segments, including the nucleic acid purification and isolation market, the laboratory information management systems market, the cell-based assays market, the research ELISA market, the high content screening market, the liquid chromatography market, the protein electrophoresis market, the RNAi market, and the proteom
'/>"/>

SOURCE Frost & Sullivan
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Transport Pharmaceuticals Receives Coveted Frost & Sullivan Technology Innovation Award
2. Nonin Medical, Inc. Receives Frost & Sullivans 2007 Award for Product Differentiation Innovation
3. Digirad Corporation to Receive Frost & Sullivan 2007 North American Award for Product Strategy
4. Signalife Wins Second Frost & Sullivan Technology Award
5. AdvanDx Receives Frost & Sullivans Rapid In-Vitro Diagnostic Technology Innovation of the Year Award
6. Modigene Announces Closing of $12 Million Financing by Members of The Frost Group
7. WuXi PharmaTech (NYSE: WX) Wins the 2008 Frost & Sullivan Award for Best in Class Outsourced R&D in Pharmaceuticals and Biotechnology
8. Exiqon Receives the 2008 Frost & Sullivan Growth Strategy Leadership Award
9. Athera Biotechnology Founder Johan Frostegard and His Colleagues Win NACB Distinguished Abstract Award at AACC 2008
10. Vascular Biogenics Ltd. Presented With the Frost & Sullivan 2008 European Gene Expression Targeting Platform Technology Innovation Award
11. Frost & Sullivan Recognizes Kionixs Dominance in the MEMS Accelerometers Market Through Product Line Strategy
Post Your Comments:
*Name:
*Comment:
*Email: